Lucas Ward
Stock Analyst at Ascendiant Capital
(0.47)
# 4,201
Out of 5,124 analysts
26
Total ratings
23.08%
Success rate
-34.25%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Maintains: Buy | $9 → $9.2 | $3.09 | +197.73% | 4 | Dec 22, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $2.03 | +170.94% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $3 → $2.8 | $0.51 | +450.86% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $4.60 | +400.00% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.46 | +187.67% | 6 | Nov 20, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $0.20 | +1,350,575.34% | 2 | Jul 29, 2024 |
HeartSciences
Dec 22, 2025
Maintains: Buy
Price Target: $9 → $9.2
Current: $3.09
Upside: +197.73%
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $2.03
Upside: +170.94%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $3 → $2.8
Current: $0.51
Upside: +450.86%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $4.60
Upside: +400.00%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.46
Upside: +187.67%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $0.20
Upside: +1,350,575.34%